All Clarivate websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.

More information on our cookie policy.

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
  • Special reports
    • Aging
    • Artificial intelligence
    • Coronavirus
    • IVDs on the rise
    • Top Biopharma Trends of 2021
    • Top Med-tech Trends of 2021
    • Premium reports
      • BioWorld Financings Reports
      • Disease Incidence & Prevalence Summaries

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, August 13, 2022
Home » Topics » Financings

Financings
Financings RSS Feed RSS

Financings for March 5, 2020

March 5, 2020
No Comments
Biopharmas raising money in public or private financings, including: Baudax, Enlivex, Titan.
Read More

Financings for March 4, 2020

March 4, 2020
No Comments
Med-tech firms raising money in public or private financings, including: Nanostring Technologies.
Read More

Financings for March 4, 2020

March 4, 2020
No Comments
Biopharmas raising money in public or private financings, including: Akari Therapeutics, Amunix Pharmaceuticals, Bridgebio Pharma, Cinclus Pharma Holding, Imara, Novan, Pacylex, Tonix, Vaxil, Zogenix.
Read More

Financings for March 3, 2020

March 3, 2020
No Comments
Biopharmas in Asia-Pacific raising money in public or private financings, including: Biolexis, Outlook.
Read More

Financings for March 3, 2020

March 3, 2020
No Comments
Med-tech firms raising money in public or private financings, including: Daxor.
Read More
3-3-element-science-jewel.png

Element Science raises $145.6M series C round to back hospital-to-home, cardiac wearable

March 3, 2020
By Stacy Lawrence
No Comments
San Francisco-based startup Element Science Inc. has raised a massive financing in support of the first product that is part of its next-generation digital wearable platform. The $145.6 million series C financing is slated to support the company through clinical trial completion and commercial launch of its Jewel Patch Wearable Cardioverter Defibrillator.
Read More
3-3-Adherium-interim-CEO.png

Adherium raises AU$5M following management reshuffle, revamped commercial strategy

March 3, 2020
By Tamra Sami
No Comments
PERTH, Australia – Australian medication adherence technology firm Adherium Ltd. is relaunching itself after a management reshuffle and a successful capital raise of AU$5.4 million (US$3.5 million) to deploy a new commercial strategy.
Read More

Financings for March 3, 2020

March 3, 2020
No Comments
Biopharmas raising money in public or private financings, including: Akouos, Emmaus Life Sciences, Lipidio Pharmaceuticals, Pliant Therapeutics, Xortx Therapeutics.
Read More

Financings for March 2, 2020

March 2, 2020
No Comments
Med-tech firms raising money in public or private financings, including: Biocept, Cn Bio Innovations, Dermtech.
Read More
Life ring buoy floating in water

Redmile, Sofinnova back Redx turnaround with $34M equity, debt funding

March 2, 2020
By Cormac Sheridan
No Comments
DUBLIN – Redx Pharma plc has put together a rescue package with two heavyweight investors that should ensure the company’s immediate future. Redmile Group LLC and Sofinnova Partners plan to provide up to £26.3 million (US$33.6 million) in funding to the struggling drug discovery and development firm.
Read More
Previous 1 2 … 260 261 262 263 264 265 266 267 268 … 314 315 Next

Popular Stories

  • Free access to BioWorld coronavirus articles

    BioWorld
    The articles in this collection are from BioWorld’s ongoing coverage of the COVID-19 coronavirus pandemic. They are available for free with registration. Note...
  • Today's news in brief

    BioWorld
    BioWorld briefs for Aug. 12, 2022.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Aug. 12, 2022.
  • Amvuttra

    Alnylam’s Amvuttra rare disease drug among positive recommendations from Europe’s CHMP

    BioWorld
    Alnylam Pharmaceuticals Inc.’s Amvuttra (vutrisiran), a treatment for the rare disease hereditary transthyretin-mediated amyloidosis, was among medicines...
  • Pig organ cells

    Whole body cellular function recovery in pigs after death

    Science
    A new system for restoring cell function and tissues in mammals after death could expand the availability of organs for transplantation. The research also opens...
black cortellis ad

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Archives
    • Today's news
    • Search BioWorld Science
    • About
  • More
    • About
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
Follow Us

Copyright ©2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing